Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Neurobehavioral disorders.
Association of vitamin D and multiple sclerosis in India.
Danish translation and psychometric testing of the Rivermead Mobility Index.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
iPINBPA: AN INTEGRATIVE NETWORK-BASED FUNCTIONAL MODULE DISCOVERY TOOL FOR GENOME-WIDE ASSOCIATION STUDIES.
CXCL13 antibody for the treatment of autoimmune disorders.
Integrating the ICF with positive psychology: Factors predicting role participation for mothers with multiple sclerosis.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Glial influence on the blood brain barrier.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Temporal reorganization to overcome monocular demyelination.
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: Yes.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.

Pages